Latest presentation

Fourth quarter 2018 results

Loading video...

Tromsø, Norway, 30 January 2019 – Biotec Pharmacon (OSE: Biotec) announces its Q4 2018 results and full year 2018 results to 31 December 2018. Highlights for Q4 and full year 2018 Group sales were up 10% to NOK 19.5 million in Q4 2018 (Q4 2017: NOK 17.7 million), due to record enzymes…

View more